General Surgery Department, Mansoura University Hospitals, Mansoura, 35516, Egypt.
General Surgery Department, King Faisal Medical Complex, Taif, Saudi Arabia.
BMC Surg. 2021 Dec 7;21(1):414. doi: 10.1186/s12893-021-01410-0.
Oncoplastic Breast surgeries (OBS) in breast cancer have evolved to preserve the cancerous breast rather than its amputation to improve postoperative cosmetic results. The lack of evidence to support the oncological safety and benefits of OBS is questionable. In this study, we evaluate various aspects of oncoplastic surgeries with a focused monitoring of aesthetic results and oncological safety.
This was a multi-center observational study focused on the statistics of data collected from cases who underwent oncoplastic surgeries from the cohort of breast cancer candidates at Mansoura University Hospitals/Egypt and King Faisal Medical Complex/KSA from January 2015 to June 2018. All data were analyzed carefully using SPSS v-26.
Eighty cases who underwent different oncoplastic surgeries were included and reviewed for the aesthetic outcome and oncological safety. The recurrence rate was found to be 2.5%. The breast impact treatment scale assessment method was used to analyze the aesthetic outcomes, and average scores were accepted in 90% of patients.
The oncoplastic breast surgeries are feasible and they had a high rate of oncological safety with the maintenance of good aesthetic outcomes and patient satisfaction.
乳腺癌的肿瘤整形乳房切除术（OBS）已经发展到保留癌性乳房而不是切除乳房，以改善术后美容效果。OBS 在肿瘤学安全性和益处方面缺乏证据支持是值得怀疑的。在这项研究中，我们评估了肿瘤整形手术的各个方面，重点关注美容效果和肿瘤学安全性。
这是一项多中心观察性研究，重点关注从 2015 年 1 月至 2018 年 6 月在曼苏拉大学医院/埃及和法伊萨尔国王医疗综合体/沙特阿拉伯的乳腺癌候选人群中接受肿瘤整形手术的病例数据的统计数据。所有数据均使用 SPSS v-26 进行仔细分析。
共纳入 80 例接受不同肿瘤整形手术的患者，对其美容效果和肿瘤学安全性进行了评估。发现复发率为 2.5%。使用乳房影响治疗量表评估方法分析美容效果，90%的患者接受了平均评分。
肿瘤整形乳房切除术是可行的，具有较高的肿瘤学安全性，同时保持良好的美容效果和患者满意度。
